{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:42:28Z","timestamp":1792640548108,"version":"4.5.0"},"reference-count":196,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xjidi.2021.100001","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T04:07:32Z","timestamp":1611547652000},"page":"100001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenesis Underlie Important Future Directions"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-9001","authenticated-orcid":false,"given":"Simon W.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-6881","authenticated-orcid":false,"given":"Melodi Javid","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-3489","authenticated-orcid":false,"given":"Paula","family":"Mariottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-5121","authenticated-orcid":false,"given":"Tarannum","family":"Jaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8139-9110","authenticated-orcid":false,"given":"Amanda S.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2021.100001_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib2","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1073\/pnas.0911755107","article-title":"Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor","volume":"107","author":"Alam","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xjidi.2021.100001_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09546634.2015.1088128","article-title":"Cyclosporine treatment of severe hidradenitis suppurativa--a case series","volume":"27","author":"Anderson","year":"2016","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.xjidi.2021.100001_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2019.09.019","article-title":"Characterizing inpatient hospitalizations for hidradenitis suppurativa in the United States","volume":"82","author":"Anzaldi","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn\u2019s disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib7","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/jdv.15160","article-title":"Anti-TNF-\u03b1 therapy modulates mTORC1 signalling in hidradenitis suppurativa","volume":"33","author":"Balato","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820139.2016.1230867","article-title":"Interferon-gamma (IFN-\u03b3) is elevated in wound exudate from hidradenitis suppurativa","volume":"46","author":"Banerjee","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.xjidi.2021.100001_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdv.15332","article-title":"Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients","volume":"33","author":"Bettoli","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jaad.2020.06.042","article-title":"Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa","volume":"83","author":"Bettuzzi","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib11","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/j.jaad.2012.06.011","article-title":"Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A","volume":"67","author":"Bianchi","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ja.2015.18","article-title":"Linezolid, vancomycin and daptomycin modulate cytokine production, toll-like receptors and phagocytosis in a human in\u00a0vitro model of sepsis","volume":"68","author":"Bode","year":"2015","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.xjidi.2021.100001_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/DSS.0000000000002323","article-title":"Systematic review of complications and recurrences after surgical interventions in hidradenitis suppurativa","volume":"46","author":"Bouazzi","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib16","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.humic.2019.100063","article-title":"Beyond the gut: skin microbiome compositional changes are associated with BMI","volume":"13","author":"Brandwein","year":"2019","journal-title":"Hum Microbiome J"},{"key":"10.1016\/j.xjidi.2021.100001_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/00222615-48-1-103","article-title":"Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa","volume":"48","author":"Brook","year":"1999","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.xjidi.2021.100001_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib21","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1111\/ced.13906","article-title":"Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa","volume":"44","author":"Cao","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2018.12.017","article-title":"Guselkumab in the treatment of hidradenitis suppurativa: a retrospective chart review","volume":"81","author":"Casseres","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jdcr.2017.12.010","article-title":"Ertapenem rescue therapy in hidradenitis suppurativa","volume":"4","author":"Chahine","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.xjidi.2021.100001_bib24","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1073\/pnas.1307855110","article-title":"Complement modulates the cutaneous microbiome and inflammatory milieu","volume":"110","author":"Chehoud","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xjidi.2021.100001_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/intimm\/dxr110","article-title":"IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1\u03b2 by keratinocytes via the ROS-NLRP3-caspase-1 pathway","volume":"24","author":"Cho","year":"2012","journal-title":"Int Immunol"},{"key":"10.1016\/j.xjidi.2021.100001_bib26","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/AAC.47.12.3704-3707.2003","article-title":"Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells","volume":"47","author":"Choi","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xjidi.2021.100001_bib27","doi-asserted-by":"crossref","DOI":"10.5070\/D32310036990","article-title":"Hormonal therapies for hidradenitis suppurativa: review","volume":"23","author":"Clark","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.xjidi.2021.100001_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007353","article-title":"Innate antimicrobial immunity in the skin: a protective barrier against bacteria, viruses, and fungi","volume":"14","author":"Coates","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.xjidi.2021.100001_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216249","article-title":"The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin","volume":"14","author":"Coates","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2021.100001_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19895488","article-title":"Hidradenitis suppurativa: infection, autoimmunity, or both?","volume":"11","author":"Constantinou","year":"2019","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2013.06.042","article-title":"Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"69","author":"Cosmatos","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib39","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/nu11081781","article-title":"The safety and impact of a model of intermittent, time-restricted circadian fasting (\u201cRamadan Fasting\u201d) on hidradenitis suppurativa: insights from a multicenter, observational, cross-over, pilot, exploratory study","volume":"11","author":"Damiani","year":"2019","journal-title":"Nutrients"},{"issue":"Suppl. 1","key":"10.1016\/j.xjidi.2021.100001_bib40","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jaad.2015.07.043","article-title":"New and traditional surgical approaches\u00a0to\u00a0hidradenitis suppurativa","volume":"73","author":"Danby","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib41","doi-asserted-by":"crossref","first-page":"6018675","DOI":"10.1155\/2017\/6018675","article-title":"mTOR signaling in cardiometabolic disease, cancer, and aging","volume":"2017","author":"Das","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.xjidi.2021.100001_bib42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2016.04.045","article-title":"Hidradenitis suppurativa (HS) and Down syndrome (DS): increased prevalence and a younger age of hidradenitis symptom onset","volume":"75","author":"Denny","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","volume":"148","author":"Dr\u00e9no","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijantimicag.2014.04.020","article-title":"Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics","volume":"44","author":"Dubourg","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xjidi.2021.100001_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ecco-jcc\/jjw070","article-title":"Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa","volume":"10","author":"Eppinga","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.xjidi.2021.100001_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2016.08.001","article-title":"Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa","volume":"76","author":"Fischer","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","article-title":"Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases","volume":"165","author":"Francisco","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xjidi.2021.100001_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319830646","article-title":"Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms","volume":"10","author":"Frew","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaad.2020.05.007","article-title":"The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: an open-label cohort study","volume":"83","author":"Frew","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib51","article-title":"Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study [e-pub ahead of print]","author":"Frew","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100001_bib54","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jaad.2019.09.071","article-title":"High-dose, high-frequency infliximab: a novel treatment paradigm for hidradenitis suppurativa","volume":"82","author":"Ghias","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cyto.2013.03.008","article-title":"Haplotypes of IL-12R\u03b21 impact on the clinical phenotype of hidradenitis suppurativa","volume":"62","author":"Giatrakos","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.xjidi.2021.100001_bib57","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5021\/ad.2018.30.4.462","article-title":"A\u00a0case of moderate hidradenitis suppurativa and psoriasis treated with secukinumab","volume":"30","author":"Giuseppe","year":"2018","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00403-019-02018-4","article-title":"Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa","volume":"312","author":"Gonz\u00e1lez-L\u00f3pez","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2021.100001_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib61","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1101\/gr.075549.107","article-title":"NISC Comparative Sequencing Program, Bouffard GG, et\u00a0al. A diversity profile of the human skin microbiota","volume":"18","author":"Grice","year":"2008","journal-title":"Genome Res"},{"key":"10.1016\/j.xjidi.2021.100001_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139930","article-title":"Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis","volume":"5","author":"Gudjonsson","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xjidi.2021.100001_bib63","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis suppurativa, France","volume":"20","author":"Guet-Revillet","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study","volume":"65","author":"Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib66","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","article-title":"Functional significance of non-neuronal acetylcholine in skin epithelia","volume":"80","author":"Hana","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.xjidi.2021.100001_bib67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00403-019-02012-w","article-title":"Serum IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3 levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome","volume":"312","author":"Hayran","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2021.100001_bib68","article-title":"Increased expression profile of NCSTN, Notch and PI3K\/AKT3 in hidradenitis suppurativa [e-pub ahead of print]","author":"Hessam","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib69","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.16019","article-title":"Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop","volume":"178","author":"Hessam","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00403-019-01965-2","article-title":"Identification of bacterial DNA in the peripheral blood of patients with active hidradenitis suppurativa","volume":"312","author":"Hisp\u00e1n","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2021.100001_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2021.100001_bib72","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2011.07.020","article-title":"Expression of innate defense antimicrobial peptides in hidradenitis suppurativa","volume":"66","author":"Hofmann","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib73","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa","volume":"136","author":"Hotz","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000477207","article-title":"A\u00a0new perspective on isotretinoin treatment of hidradenitis suppurativa: a retrospective chart review of patient outcomes","volume":"233","author":"Huang","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100001_bib75","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.xjidi.2021.100001_bib76","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2007.08425.x","article-title":"Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor","volume":"158","author":"Hunger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib77","series-title":"Dermatologic Surgery: Principles and Practice","first-page":"729","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach","author":"Hurley","year":"1989"},{"key":"10.1016\/j.xjidi.2021.100001_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12971-014-0026-3","article-title":"Scratching the surface \u2013 tobacco-induced bacterial biofilms","volume":"13","author":"Hutcherson","year":"2015","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib79","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British\u00a0Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib80","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib81","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humic.2017.09.002","article-title":"The diabetic foot microbiota: a review","volume":"5\u20136","author":"Jneid","year":"2017","journal-title":"Hum Microbiome J"},{"key":"10.1016\/j.xjidi.2021.100001_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100001_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08820139.2017.1377227","article-title":"Inherent differences in keratinocyte function in hidradenitis suppurativa: evidence for the role of IL-22 in disease pathogenesis","volume":"47","author":"Jones","year":"2018","journal-title":"Immunol Invest"},{"key":"10.1016\/j.xjidi.2021.100001_bib86","article-title":"Therapeutic response to secukinumab in a 36-year-old woman with hidradenitis suppurativa","volume":"2018","author":"J\u00f8rgensen","year":"2018","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib87","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jid.2017.10.030","article-title":"MABp1 targeting IL-1\u03b1 for moderate to severe hidradenitis suppurativa not eligible for adalimumab: a randomized study","volume":"138","author":"Kanni","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib88","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"Kanni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","article-title":"Considering hidradenitis suppurativa as a bacterial biofilm disease","volume":"65","author":"Kathju","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.xjidi.2021.100001_bib90","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ced.14199","article-title":"Successful use of guselkumab in the treatment of severe hidradenitis suppurativa","volume":"45","author":"Kearney","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib91","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib92","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory mechanisms in hidradenitis suppurativa","volume":"34","author":"Kelly","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.xjidi.2021.100001_bib93","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib94","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"Suppl. 1","key":"10.1016\/j.xjidi.2021.100001_bib95","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib96","first-page":"e140","article-title":"Guselkumab in the treatment of severe hidradenitis suppurativa","volume":"33","author":"Kovacs","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.xjidi.2021.100001_bib99","first-page":"A31","article-title":"IDDF2019-ABS-0293 A microbiome pilot study: the exploration of the gut-skin axis in hidradenitis suppurativa","volume":"68","author":"Lam","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.xjidi.2021.100001_bib100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bjd.17989","article-title":"Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis","volume":"181","author":"Langan","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1999.02613.x","article-title":"Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery","volume":"140","author":"Lapins","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib102","first-page":"730","article-title":"Incidence of cancer among patients with hidradenitis suppurativa","volume":"137","author":"Lapins","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A\u00a0case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib104","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000486741","article-title":"Hidradenitis suppurativa: disease burden and etiology in skin of color","volume":"233","author":"Lee","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100001_bib105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000443648","article-title":"PASS syndrome: an IL-1-driven autoinflammatory disease","volume":"232","author":"Leuenberger","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100001_bib106","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib107","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjd.14482","article-title":"Genetic analysis of NCSTN for potential association with hidradenitis suppurativa in familial and nonfamilial patients","volume":"175","author":"Liu","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib108","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jid.2018.03.1501","article-title":"Longitudinal study of the psoriasis-associated skin microbiome during therapy with ustekinumab in a randomized phase 3b clinical trial","volume":"138","author":"Loesche","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib109","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/000313481107701131","article-title":"Squamous cell carcinoma complicating chronic suppurative hidradenitis","volume":"77","author":"Losanoff","year":"2011","journal-title":"Am Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139932","article-title":"Immunopathogenesis of hidradenitis suppurativa and response to anti\u2013TNF-\u03b1 therapy","volume":"5","author":"Lowe","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xjidi.2021.100001_bib111","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib112","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/jor.24291","article-title":"Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates","volume":"37","author":"Mandell","year":"2019","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.xjidi.2021.100001_bib113","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib114","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib116","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjd.12068","article-title":"Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa)","volume":"168","author":"Melnik","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib117","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.xjidi.2021.100001_bib119","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/jid.2012.23","article-title":"Nicastrin mutations in French families with hidradenitis suppurativa","volume":"132","author":"Miskinyte","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib120","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/jdv.13233","article-title":"Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop","volume":"30","author":"Monfrecola","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib121","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib122","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A\u00a0double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2340\/00015555-1492","article-title":"Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa","volume":"93","author":"Mozeika","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib124","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","article-title":"Skin microbiota perturbations are distinct and disease severity\u2013dependent in hidradenitis suppurativa","volume":"140","author":"Naik","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bjd.14805","article-title":"Bacterial biofilm in acute lesions of hidradenitis suppurativa","volume":"176","author":"Okoye","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib126","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaad.2019.05.022","article-title":"Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa","volume":"81","author":"Oskardmay","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/eji.200636999","article-title":"Notch signaling is activated by TLR stimulation and regulates macrophage functions","volume":"38","author":"Palaga","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xjidi.2021.100001_bib128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1099\/0022-1317-49-7-675","article-title":"Antimicrobial activity of nicotine against a spectrum of bacterial and fungal pathogens","volume":"49","author":"Pavia","year":"2000","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.xjidi.2021.100001_bib129","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib130","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/jid.2012.162","article-title":"Mutations in the \u03b3-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)","volume":"132","author":"Pink","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.17822","article-title":"Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa","volume":"181","author":"Prussick","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib132","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/DSS.0000000000001693","article-title":"Pain management in patients with hidradenitis suppurativa requiring surgery","volume":"45","author":"Puza","year":"2019","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib133","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/infdis\/jit005","article-title":"Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men","volume":"207","author":"Redel","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xjidi.2021.100001_bib134","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3899\/jrheum.130977","article-title":"Hidradenitis suppurativa associated with spondyloarthritis \u2014 results from a multicenter national prospective study","volume":"41","author":"Richette","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib136","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib137","first-page":"239","article-title":"The role of androgens and estrogens in hidradenitis suppurativa - a systematic review","volume":"24","author":"Riis","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.xjidi.2021.100001_bib138","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib139","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib140","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jid.2019.11.011","article-title":"Predictive metagenomic analysis reveals a role of cutaneous dysbiosis in the development of hidradenitis suppurativa","volume":"140","author":"Ring","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib141","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib142","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jid.2020.02.046","article-title":"The surface microbiome of clinically unaffected skinfolds in hidradenitis suppurativa: A cross-sectional culture-based and 16S rRNA gene amplicon sequencing study in 60 patients","volume":"140","author":"Riverain-Gillet","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib143","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fmicb.2017.02306","article-title":"Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.xjidi.2021.100001_bib144","first-page":"684","article-title":"The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata","volume":"20","author":"Rosner","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-97-4-520","article-title":"Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata","volume":"97","author":"Rosner","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib146","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2021.100001_bib147","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13578-015-0060-8","article-title":"Deciphering the role of interleukin-22 in metabolic alterations","volume":"5","author":"Sabat","year":"2015","journal-title":"Cell Biosci"},{"key":"10.1016\/j.xjidi.2021.100001_bib148","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T\u00a0cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.xjidi.2021.100001_bib149","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/exd.13919","article-title":"Matrix remodelling and MMP expression\/activation are associated with hidradenitis suppurativa skin inflammation","volume":"28","author":"Sanchez","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib150","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ad.2013.09.011","article-title":"Ustekinumab for hidradenitis suppurativa: a case report","volume":"105","author":"Santos-P\u00e9rez","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.xjidi.2021.100001_bib151","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib152","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","article-title":"Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment","volume":"166","author":"Sartorius","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib153","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bjd.12105","article-title":"Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa","volume":"168","author":"Savva","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib154","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/bjd.17854","article-title":"A\u00a0new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26","volume":"181","author":"Scala","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xjidi.2021.100001_bib156","doi-asserted-by":"crossref","DOI":"10.5070\/D3212025709","article-title":"Extensive hidradenitis suppurativa (HS) Hurly stage III disease treated with intravenous (IV) linezolid and meropenem with rapid remission","volume":"21","author":"Scheinfeld","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.xjidi.2021.100001_bib157","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib158","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaad.2008.12.033","article-title":"Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa","volume":"61","author":"Schlapbach","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192717","article-title":"Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators","volume":"13","author":"Schmidt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2021.100001_bib160","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jid.2019.06.151","article-title":"Loss of skin microbial diversity and alteration of bacterial metabolic function in hidradenitis suppurativa","volume":"140","author":"Schneider","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib161","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib162","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.xjidi.2021.100001_bib163","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/ced.13959","article-title":"Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis","volume":"44","author":"Shanmugam","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib164","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib165","doi-asserted-by":"crossref","first-page":"e55380","DOI":"10.1371\/journal.pone.0055380","article-title":"Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus","volume":"8","author":"Shu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2021.100001_bib166","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2009.08.001","article-title":"Hidradenitis suppurativa and smoking","volume":"62","author":"Simonart","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib167","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1203475419874412","article-title":"Weight loss and dietary interventions for hidradenitis suppurativa: a systematic review","volume":"24","author":"Sivanand","year":"2020","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib168","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00124743-200202000-00005","article-title":"A\u00a0study of musculoskeletal manifestations in 12 patients with SAPHO syndrome","volume":"8","author":"Steinhoff","year":"2002","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib169","first-page":"397","article-title":"Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-\u03baB signaling pathways","volume":"4","author":"Sun","year":"2015","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.xjidi.2021.100001_bib170","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A\u00a0crucial role for interleukin (IL)-1 in the induction of IL-17\u2013producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.xjidi.2021.100001_bib171","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis\u2014probiotics as new tools for skin disorder management?","volume":"28","author":"Sz\u00e1nt\u00f3","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib172","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1203475416659858","article-title":"Acitretin","volume":"21","author":"Tan","year":"2017","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.xjidi.2021.100001_bib173","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/jdv.14389","article-title":"Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa","volume":"31","author":"Thomi","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib174","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/bjd.15458","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","volume":"177","author":"Thomi","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib175","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2020.01.042","article-title":"Variability in skin microbiota between smokers, former smokers, and nonsmokers","volume":"83","author":"Thompson","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib176","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib177","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.15769","article-title":"Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib178","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4097574","article-title":"MMP8 is increased in lesions and blood of acne inversa patients: a potential link to skin destruction and metabolic alterations","volume":"2016","author":"Tsaousi","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.xjidi.2021.100001_bib179","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib180","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib181","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjd.13002","article-title":"The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease","volume":"171","author":"van der Zee","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib182","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib183","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex\u00a0vivo study","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib184","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy","volume":"26","author":"Van Raemdonck","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.xjidi.2021.100001_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib186","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5606\/ArchRheumatol.2017.6067","article-title":"Interleukin-17A levels increase in serum of children with juvenile idiopathic arthritis","volume":"32","author":"Vijatov-Djuric","year":"2017","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib187","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2021.100001_bib188","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib189","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial","volume":"80","author":"Vossen","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib191","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaad.2016.07.024","article-title":"Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study","volume":"76","author":"Vossen","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib192","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib193","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.xjidi.2021.100001_bib194","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13564","article-title":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes","volume":"514","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2021.100001_bib195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaad.2017.02.026","article-title":"Apremilast in the treatment of moderate to severe hidradenitis suppurativa: a case series of 9 patients","volume":"76","author":"Weber","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100001_bib196","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.48.6.1974-1982.2004","article-title":"Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines","volume":"48","author":"Weiss","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xjidi.2021.100001_bib197","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xjidi.2021.100001_bib198","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200939687","article-title":"The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis","volume":"39","author":"Wolk","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xjidi.2021.100001_bib199","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.xjidi.2021.100001_bib200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/AAC.50.1.396-398.2006","article-title":"Rifampin augments cytokine-induced nitric oxide production in human alveolar epithelial cells","volume":"50","author":"Yuhas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xjidi.2021.100001_bib201","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01746-18","article-title":"Role of rifampin against staphylococcal biofilm infections in\u00a0vitro, in animal models, and in orthopedic-device-related infections","volume":"63","author":"Zimmerli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xjidi.2021.100001_bib202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization \u2013 systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026721000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026721000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:00:47Z","timestamp":1763020847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026721000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":196,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2667026721000011"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2021.100001","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenesis Underlie Important Future Directions","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2021.100001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100001"}}